Find a Tender
complete
Official procurement procedure
NP39724 Generic and Biosimilar Cancer Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published43
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP39724 Generic and Biosimilar Cancer Medicines". Published status: complete. Published value: Value not published. 43 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
6.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 579 active published awards; 550 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published27 Feb 2025, 09:17 GMT | Last source update27 Feb 2025, 09:17 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04870b | ||
What is being bought
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
What changed
From the official release history
- tender value changed
27 Feb 2025, 09:17 GMT - Status changed to complete
27 Feb 2025, 09:17 GMT - Official notice release published
27 Feb 2025, 09:17 GMT - Submission deadline changed to published date
27 Feb 2025, 09:17 GMT - Buyer information updated
27 Feb 2025, 09:17 GMT - Published value updated to £57,386,767
2 Aug 2024, 10:51 BST - Status changed to active
2 Aug 2024, 10:51 BST - Official notice release published
2 Aug 2024, 10:51 BST - Submission deadline changed to 2 Sept 2024, 12:00 BST
2 Aug 2024, 10:51 BST - Buyer information updated
2 Aug 2024, 10:51 BST
Lots and requirements (43)
Published by the contracting authority
- Lot 1 · #1Bendamustine Powder For Solution For InfusioncancelledPublished valueNot publishedSupply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #10Doxorubicin Solution For Injection VialscancelledPublished valueNot publishedSupply of Doxorubicin Solution For Injection Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #11Fluorouracil 25MG/ML InjectionscancelledPublished valueNot publishedSupply of Fluorouracil Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #12Fluorouracil 50MG/ML InjectionscancelledPublished valueNot publishedSupply of Fluorouracil 50MG/ML Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #13Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #14Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #15Gemcitabine Powder For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #16Idarubicin Hydrochloride Injection Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Idarubicin Hydrochloride Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #17Ifosfamide Injection Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #18Irinotecan Hydrochloride InjectionscancelledPublished valueNot publishedSupply of Irinotecan Hydrochloride Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #19Lanreotide Injection Prefilled Syringes (unbundled - without homecare)cancelledPublished valueNot publishedSupply of Lanreotide Injection Prefilled Syringes (unbundled - without homecare). The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #2Capecitabine TabletscancelledPublished valueNot publishedSupply of Capecitabine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #20Lanreotide Injection Prefilled Syringes (bundled - with homecare)cancelledPublished valueNot publishedSupply of Lanreotide Injection Prefilled Syringes (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #21Methotrexate Without Preservatives InjectionscancelledPublished valueNot publishedSupply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #22Methotrexate Oral SolutioncancelledPublished valueNot publishedSupply of Methotrexate Oral Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 16 · #23Oxaliplatin Vial SolutioncancelledPublished valueNot publishedSupply of Oxaliplatin Vial Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 17 · #24Paclitaxel Concentrate For Intravenous InfusioncancelledPublished valueNot publishedSupply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 18 · #25Temozolomide CapsulescancelledPublished valueNot publishedSupply of Temozolomide Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 19 · #26Vincristine Without Preservatives InjectioncancelledPublished valueNot publishedSupply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 20 · #27Vinorelbine InjectionscancelledPublished valueNot publishedSupply of Vinorelbine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 21 · #28Aprepitant CapsulescancelledPublished valueNot publishedSupply of Aprepitant Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 22 · #29Topotecan CapsulescancelledPublished valueNot publishedSupply of Topotecan Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 23 · #3Carboplatin InjectionscancelledPublished valueNot publishedSupply of Carboplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework . Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 24 · #30Topotecan Concentrate For Solution For InfusioncancelledPublished valueNot publishedSupply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 25 · #31Octreotide InjectionscancelledPublished valueNot publishedSupply of Octreotide Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 26 · #32Filgrastim Pre-Filled SyringescancelledPublished valueNot publishedSupply of Filgrastim Pre-Filled Syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 27 · #33Pemetrexed Powder For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Pemetrexed Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 28 · #34Pemetrexed (25Mg/Ml) Solution For Infusion VialscancelledPublished valueNot publishedSupply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 29 · #35Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare)cancelledPublished valueNot publishedSupply of Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants]. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 30 · #36Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare)cancelledPublished valueNot publishedSupply of Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 31 · #37Etoposide InjectionscancelledPublished valueNot publishedSupply of Etoposide Injection to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 32 · #38Dasatinib TabletscancelledPublished valueNot publishedSupply of Dasatinib Tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 33 · #39Range Generic & Biosimilar Cancer Medicines (unranked)cancelledPublished valueNot publishedSupply of Range of Generic & Biosimilar Medicines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per product line to a maximum of six (6) suppliers. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 34 · #4Cisplatin InjectionscancelledPublished valueNot publishedSupply of Cisplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 35 · #40Idarubicin Hydrochloride Solution For Infusion VialscancelledPublished valueNot publishedSupply of Idarubicin Hydrochloride Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 36 · #41Range of Generic Cancer Medicines (single supplier)cancelledPublished valueNot publishedSupply of Range of Generic Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 37 · #42Bosutinib TabletscancelledPublished valueNot publishedSupply of Bosutinib tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 38 · #43Paclitaxel Albumin VialscancelledPublished valueNot publishedSupply of Paclitaxel Albumin Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier per product line. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 39 · #5Cyclophosphamide Injection, Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 40 · #6Cytarabine InjectionscancelledPublished valueNot publishedSupply of Cytarabine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 41 · #7Dacarbazine InjectionscancelledPublished valueNot publishedSupply of Dacarbazine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 42 · #8Disodium Folinate InjectionscancelledPublished valueNot publishedSupply of Disodium Folinate Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 43 · #9Docetaxel Concentrate For Solution For InfusioncancelledPublished valueNot publishedSupply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
27 Feb 2025, 09:17 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 13 Jan 2025, 00:00 GMT · £30,764 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £26,461 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £71,718 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £72,777 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £70,677 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £14,717 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £75,886 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £29,968 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £461,565 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £64,662 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £159,229 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £1,324,548 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £681,188 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £83,938 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £9,476 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £40,456 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £110,289 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £26,940 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £24,879 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £11,323 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £1,160 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £517,465 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £652 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £105,174 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £29,694 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £79,792 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £1,714,852 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £26,994 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £3,432,063 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £112,414 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £440,653 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £17,607 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £190,471 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £266,998 - Contract active
Signed 13 Jan 2025, 00:00 GMT · £69,512
Commercial outcome and competition
Awards Accord-UK Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active medac Pharma LLP Not published · Not published · active Accord-UK Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials Not published · Not published · unsuccessful Day Lewis Medical Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Accord-UK Ltd Not published · Not published · active Ipsen Ltd, Mercury Pharmaceuticals Limited Not published · Not published · active Ipsen Ltd, Mercury Pharmaceuticals Limited Not published · Not published · active medac Pharma LLP Not published · Not published · active Rosemont Pharmaceuticals Not published · Not published · active Seacross Pharmaceuticals Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Ranbaxy UK Ltd Not published · Not published · active Teva UK Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active Aprepitant Capsules Not published · Not published · unsuccessful Fluorouracil 25MG/ML Injections Not published · Not published · unsuccessful Accord-UK Ltd Not published · Not published · active Octreotide Injections Not published · Not published · unsuccessful Accord-UK Ltd Not published · Not published · active Seacross Pharmaceuticals Not published · Not published · active Accord-UK Ltd Not published · Not published · active Teva UK Ltd Not published · Not published · active Etoposide Injections Not published · Not published · unsuccessful MSN Labs, STADA UK - Thornton & Ross, Sandoz, Teva UK Ltd, Viatris UK Healthcare Ltd, Zentiva UK Not published · Not published · active Accord-UK Ltd, Baxter Healthcare Ltd, Celltrion Healthcare United Kingdom Limited, Dr Reddy's Laboratories (UK) Ltd, Organon Pharma (UK) Ltd., Pfizer Ltd, Roche Products Ltd, STADA UK - Thornton & Ross, Sandoz, Seacross Pharmaceuticals, Tillomed Laboratories ltd, Zentiva UK Not published · Not published · active Pfizer Ltd Not published · Not published · active Gemcitabine Powder For Solution For Infusion Vials Not published · Not published · unsuccessful Accord-UK Ltd, Aspen Pharmacare UK Limited, Aspire Pharma Ltd, Baxter Healthcare Ltd, CST Pharma Ltd, Celix Pharma Ltd., Chugai Pharma UK Ltd, Cipla EU Ltd, Day Lewis Medical Ltd, Dr Reddy's Laboratories (UK) Ltd, Esteve Pharmaceuticals Ltd, Flexipharm Austrading Limited, Glenmark Pharmaceuticals Europe Ltd, MSN Labs, Martindale Pharma Not published · Not published · active STADA UK - Thornton & Ross Not published · Not published · active STADA UK - Thornton & Ross, Zentiva UK Not published · Not published · active Teva UK Ltd Not published · Not published · active Idarubicin Hydrochloride Injection Powder For Reconstitution Not published · Not published · unsuccessful Topotecan Capsules Not published · Not published · unsuccessful Fresenius Kabi Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active |
Contracts Bendamustine Powder For Solution For Infusion £30,764 · signed 13 Jan 2025, 00:00 GMT · active Cytarabine Injections £26,461 · signed 13 Jan 2025, 00:00 GMT · active Dacarbazine Injections £71,718 · signed 13 Jan 2025, 00:00 GMT · active Disodium Folinate Injections £72,777 · signed 13 Jan 2025, 00:00 GMT · active Docetaxel Concentrate For Solution For Infusion £70,677 · signed 13 Jan 2025, 00:00 GMT · active Doxorubicin Solution For Injection Vials £14,717 · signed 13 Jan 2025, 00:00 GMT · active Fluorouracil 50MG/ML Injections £75,886 · signed 13 Jan 2025, 00:00 GMT · active Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials £29,968 · signed 13 Jan 2025, 00:00 GMT · active Ifosfamide Injection Powder For Reconstitution £461,565 · signed 13 Jan 2025, 00:00 GMT · active Irinotecan Hydrochloride Injections £64,662 · signed 13 Jan 2025, 00:00 GMT · active Capecitabine Tablets £159,229 · signed 13 Jan 2025, 00:00 GMT · active Lanreotide Injection Prefilled Syringes (unbundled - without homecare) £1,324,548 · signed 13 Jan 2025, 00:00 GMT · active Lanreotide Injection Prefilled Syringes (bundled - with homecare) £681,188 · signed 13 Jan 2025, 00:00 GMT · active Methotrexate Without Preservatives Injections £83,938 · signed 13 Jan 2025, 00:00 GMT · active Methotrexate Oral Solution £9,476 · signed 13 Jan 2025, 00:00 GMT · active Oxaliplatin Vial Solution £40,456 · signed 13 Jan 2025, 00:00 GMT · active Paclitaxel Concentrate For Intravenous Infusion £110,289 · signed 13 Jan 2025, 00:00 GMT · active Temozolomide Capsules £26,940 · signed 13 Jan 2025, 00:00 GMT · active Vincristine Without Preservatives Injection £24,879 · signed 13 Jan 2025, 00:00 GMT · active Vinorelbine Injections £11,323 · signed 13 Jan 2025, 00:00 GMT · active Topotecan Concentrate For Solution For Infusion £1,160 · signed 13 Jan 2025, 00:00 GMT · active Filgrastim Pre-Filled Syringes £517,465 · signed 13 Jan 2025, 00:00 GMT · active Pemetrexed Powder For Solution For Infusion Vials £652 · signed 13 Jan 2025, 00:00 GMT · active Pemetrexed (25Mg/Ml) Solution For Infusion Vials £105,174 · signed 13 Jan 2025, 00:00 GMT · active Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare) £29,694 · signed 13 Jan 2025, 00:00 GMT · active Dasatinib Tablets £79,792 · signed 13 Jan 2025, 00:00 GMT · active Range Generic & Biosimilar Cancer Medicines (unranked) £1,714,852 · signed 13 Jan 2025, 00:00 GMT · active Idarubicin Hydrochloride Solution For Infusion Vials £26,994 · signed 13 Jan 2025, 00:00 GMT · active Range of Generic Cancer Medicines (single supplier) £3,432,063 · signed 13 Jan 2025, 00:00 GMT · active Bosutinib Tablets £112,414 · signed 13 Jan 2025, 00:00 GMT · active Paclitaxel Albumin Vials £440,653 · signed 13 Jan 2025, 00:00 GMT · active Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare) £17,607 · signed 13 Jan 2025, 00:00 GMT · active Carboplatin Injections £190,471 · signed 13 Jan 2025, 00:00 GMT · active Cisplatin Injections £266,998 · signed 13 Jan 2025, 00:00 GMT · active Cyclophosphamide Injection, Powder For Reconstitution £69,512 · signed 13 Jan 2025, 00:00 GMT · active |
Bid statistics bids: 2 (lot 1) electronicBids: 2 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 2 (lot 1) smeBids: 0 (lot 1) bids: 3 (lot 10) electronicBids: 3 (lot 10) foreignBidsFromEU: 0 (lot 10) foreignBidsFromNonEU: 3 (lot 10) smeBids: 0 (lot 10) bids: 2 (lot 12) electronicBids: 2 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 2 (lot 12) smeBids: 0 (lot 12) bids: 2 (lot 13) electronicBids: 2 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 2 (lot 13) smeBids: 0 (lot 13) bids: 2 (lot 17) electronicBids: 2 (lot 17) foreignBidsFromEU: 0 (lot 17) foreignBidsFromNonEU: 2 (lot 17) smeBids: 0 (lot 17) bids: 4 (lot 18) electronicBids: 0 (lot 18) foreignBidsFromEU: 0 (lot 18) foreignBidsFromNonEU: 4 (lot 18) smeBids: 0 (lot 18) bids: 2 (lot 19) electronicBids: 2 (lot 19) foreignBidsFromEU: 0 (lot 19) foreignBidsFromNonEU: 2 (lot 19) smeBids: 0 (lot 19) bids: 4 (lot 2) electronicBids: 4 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 4 (lot 2) smeBids: 0 (lot 2) bids: 2 (lot 20) electronicBids: 2 (lot 20) foreignBidsFromEU: 0 (lot 20) foreignBidsFromNonEU: 2 (lot 20) smeBids: 0 (lot 20) bids: 2 (lot 21) electronicBids: 2 (lot 21) foreignBidsFromEU: 0 (lot 21) foreignBidsFromNonEU: 2 (lot 21) smeBids: 0 (lot 21) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published